These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 10425322)

  • 1. Cross-linked amylose tablets containing alpha-amylase: an enzymatically-controlled drug release system.
    Dumoulin Y; Cartilier LH; Mateescu MA
    J Control Release; 1999 Aug; 60(2-3):161-7. PubMed ID: 10425322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzymatic degradation of cross-linked high amylose starch tablets and its effect on in vitro release of sodium diclofenac.
    Rahmouni M; Chouinard F; Nekka F; Lenaerts V; Leroux JC
    Eur J Pharm Biopharm; 2001 May; 51(3):191-8. PubMed ID: 11343882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of binary mixtures consisting of cross-linked high amylose starch and hydroxypropylmethylcellulose used in the preparation of controlled release tablets.
    Rahmouni M; Lenaerts V; Massuelle D; Doelker E; Johnson M; Leroux JC
    Pharm Dev Technol; 2003; 8(4):335-48. PubMed ID: 14601958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-amylose carboxymethyl starch matrices for oral sustained drug-release: in vitro and in vivo evaluation.
    Nabais T; Brouillet F; Kyriacos S; Mroueh M; Amores da Silva P; Bataille B; Chebli C; Cartilier L
    Eur J Pharm Biopharm; 2007 Mar; 65(3):371-8. PubMed ID: 17275270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spray-dried high-amylose sodium carboxymethyl starch: impact of α-amylase on drug-release profile.
    Nabais T; Zaraa S; Leclair G
    Drug Dev Ind Pharm; 2016 Nov; 42(11):1887-93. PubMed ID: 27109692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substituted amylose as a matrix for sustained-drug release: a biodegradation study.
    Chebli C; Cartilier L; Hartman NG
    Int J Pharm; 2001 Jul; 222(2):183-9. PubMed ID: 11427348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-linked high amylose starch for controlled release of drugs: recent advances.
    Lenaerts V; Moussa I; Dumoulin Y; Mebsout F; Chouinard F; Szabo P; Mateescu MA; Cartilier L; Marchessault R
    J Control Release; 1998 Apr; 53(1-3):225-34. PubMed ID: 9741930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NMR imaging of chitosan and carboxymethyl starch tablets: swelling and hydration of the polyelectrolyte complex.
    Wang YJ; Assaad E; Ispas-Szabo P; Mateescu MA; Zhu XX
    Int J Pharm; 2011 Oct; 419(1-2):215-21. PubMed ID: 21864660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-properties relationship in cross-linked high-amylose starch for use in controlled drug release.
    Ispas-Szabo P; Ravenelle F; Hassan I; Preda M; Mateescu MA
    Carbohydr Res; 2000 Jan; 323(1-4):163-75. PubMed ID: 10782298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The preparation and kinetic study on enzymatically-controlled drug release of isotretinoin/amylose inclusion complex].
    Wang QF; Li SM; Zhang TH; Yu J; Hu ZS; Li Y
    Yao Xue Xue Bao; 2012 Sep; 47(9):1227-30. PubMed ID: 23227555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-linked high amylose starch derivatives for drug release. II. Swelling properties and mechanistic study.
    Mulhbacher J; Ispas-Szabo P; Mateescu MA
    Int J Pharm; 2004 Jul; 278(2):231-8. PubMed ID: 15196628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Membrane formation and drug loading effects in high amylose starch tablets studied by NMR imaging.
    Thérien-Aubin H; Zhu XX; Ravenelle F; Marchessault RH
    Biomacromolecules; 2008 Apr; 9(4):1248-54. PubMed ID: 18357992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of physical parameters and lubricants on the compaction properties of granulated and non-granulated cross-linked high amylose starch.
    Rahmouni M; Lenaerts V; Massuelle D; Doelker E; Leroux JC
    Chem Pharm Bull (Tokyo); 2002 Sep; 50(9):1155-62. PubMed ID: 12237529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-linked high amylose starch derivatives for drug release III. Diffusion properties.
    Mulhbacher J; Mateescu MA
    Int J Pharm; 2005 Jun; 297(1-2):22-9. PubMed ID: 15878244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling a system of phosphated cross-linked high amylose for controlled drug release. Part 2: physical parameters, cross-linking degrees and drug delivery relationships.
    Cury BS; Castro AD; Klein SI; Evangelista RC
    Int J Pharm; 2009 Apr; 371(1-2):8-15. PubMed ID: 19124066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemically-modified polysaccharides for enzymatically-controlled oral drug delivery.
    Kost J; Shefer S
    Biomaterials; 1990 Nov; 11(9):695-8. PubMed ID: 2090305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging of high-amylose starch tablets. 3. Initial diffusion and temperature effects.
    Thérien-Aubin H; Baille WE; Zhu XX; Marchessault RH
    Biomacromolecules; 2005; 6(6):3367-72. PubMed ID: 16283767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Image analysis studies of water transport and dimensional changes occurring in the early stages of hydration in cross-linked amylose matrices.
    Moussa IS; Lenaerts V; Cartilier LH
    J Control Release; 1998 Mar; 52(1-2):63-70. PubMed ID: 9685936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucoadhesive properties of cross-linked high amylose starch derivatives.
    Mulhbacher J; Ispas-Szabo P; Ouellet M; Alex S; Mateescu MA
    Int J Biol Macromol; 2006 Dec; 40(1):9-14. PubMed ID: 16837041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxypropylated starches of varying amylose contents as sustained release matrices in tablets.
    Onofre FO; Wang YJ
    Int J Pharm; 2010 Jan; 385(1-2):104-12. PubMed ID: 19879935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.